Title : Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.

Pub. Date : 2011 Aug

PMID : 21636598






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: Polymorphisms in CYP2C9 and VKORC1 influence patients" phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. Phenprocoumon cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 AIMS: Polymorphisms in CYP2C9 and VKORC1 influence patients" phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. Phenprocoumon cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 CYP2C9 and VKORC1 genotype, weight, height, sex, age, and amiodarone use contributed to the maintenance dose of PHE and ACE. Phenprocoumon cytochrome P450 family 2 subfamily C member 9 Homo sapiens